Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2006-12-14

FDA Approved: IDARUBICIN HYDROCHLORIDE — Original Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved an original application for Idarubicin Hydrochloride by Hikma Pharmaceuticals USA Inc., adding a generic option to the market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Idarubicin hydrochloride (idarubicin hydrochloride)

Snippet

ORIG AP for IDARUBICIN HYDROCHLORIDE (IDARUBICIN HYDROCHLORIDE)